Abbott: Tachycardia trials

The registry lists 26 Tachycardia studies with Abbott as lead sponsor. 0 are open to participants now and 11 have results posted.

Phase 1 1No phase 25(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• China (CN)_Magnetic Resonance Imaging (MRI)_Implantable Cardiac Defibrillator (ICD) [CN_MRI_ICD]CompletedNCT03828357Results posted
• Advisor HD Grid Observational StudyCompletedNCT03733392Results posted
• Physiologic Pacing RegistryCompletedNCT03719040Results posted
• A Post-market Clinical Evaluation of St. Jude Medical™ MR Conditional ICD System on Patients Undergoing Magnetic Resonance ImagingCompletedNCT02877693Not applicableResults posted
• EGM Analysis in Idiopathic Outflow Tract Ventricular ArrhythmiaCompletedNCT02722577Results posted
• Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for the Reduction of Ventricular TachycardiaTerminatedNCT02130765Not applicableResults posted
• TOCCATA - Touch+™ for Catheter AblationCompletedNCT01223469Not applicableResults posted
• SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Defibrillator PatientsCompletedNCT00940888Results posted
• Therapy Cool Path Ablate VTTerminatedNCT00925522Not applicableResults posted
• AVAI: Atrial Ventricular Arrythmia IncidenceCompletedNCT00832975Results posted
• Study of New Implantable Loop RecorderCompletedNCT00746564Not applicableResults posted
• Assert-IQ Implantable Cardiac Monitor (ICM) Post Market StudyCompletedNCT06172699
• FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT StudyCompletedNCT03490201Not applicable
• Clinical Study to Confirm MRI Safety and Effectiveness Using St. Jude Medical (SJM) Cardiac Rhythm Management SystemsCompletedNCT03012568
• EnSite™ HD Grid Catheter AF/AT Mapping StudyCompletedNCT02656537Not applicable
• Evaluation of Inducible Monomorphic Ventricular Tachycardia (MMVT) in Patients With St. Jude Medical (SJM) Implantable Cardioverter Defibrillator (ICD) Systems or Cardiac Resynchronization Therapy Defibrillation (CRT-D) Systems.WithdrawnNCT02584595
• Reduction of Inappropriate Shocks of Implantable Cardioverter Defibrillators (ICDs) With Enhanced SVT DiscriminatorsCompletedNCT01963286Not applicable
• St. Jude Medical Product Longevity and Performance (SCORE) RegistryCompletedNCT01754064
• Ventricular Wall Motion CharacterizationCompletedNCT01629160
• Optimal Sensing in Atrial Tachyarrhythmia's StudyTerminatedNCT01074749Not applicable
• Substrate Modification in Stable Ventricular Tachycardia in Addition to Implantable Cardioverter Defibrillator (ICD) TherapyCompletedNCT00919373Not applicable
• OptiSense™ Performance in Detecting Atrial EpisodesCompletedNCT00870324
• Septal Positioning of Ventricular Implanted Cardioverter Defibrillator (ICD) LeadsCompletedNCT00745745Not applicable
• PAtient NOtifier Feature for Reduction of AnxietyCompletedNCT00559559Not applicable
• Dynamic Substrate Mapping (DSM) for Ischemic VTTerminatedNCT00558857Phase 1
• DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II)CompletedNCT00187187Not applicable